Previous Close | 27.42 |
1-Year Change | 41.85% |
6-Months Change | 65.18% |
3-Months Change | 27.77% |
Moving Avg (50d) | 26.622 |
Moving Avg (200d) | 21.389 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 3.79B |
Beta (3-Years) | 1.62 |
Revenue Growth (ttm) | 207.89% |
Net Profit Margin (ttm) | -36.51% |
Return On Assets (ttm) | -10.06% |
EPS (ttm) | -0.97 |
PE Ratio (ttm) | -28.27 |
Dividend Yield | % |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |